Up to 43 percent of babies born to HIV- positive mothers in developing countries become infected with the virus. In wealthier countries, intensive treatment of both mother and baby with the drug zidovudine (AZT) is used to reduce HIV transmission. Is there an alternative to this costly treatment in resource-poor settings?